Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Simona Volpi
Affiliation
National Human Genome Research Institute
ORCID
Career Start Year
2001
Papers
25
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
35660539
Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension.
Contemp Clin Trials
2022
35660539
Design and rationale of GUARDD-US: A pragmatic, randomized trial of genetic testing for APOL1 and pharmacogenomic predictors of antihypertensive efficacy in patients with hypertension.
Contemp Clin Trials
2022
34763988
Corrigendum to 'SJS/TEN 2019: From science to translation' [J. Dermatol. Sci. 98/1 (2020) 2-12].
J Dermatol Sci
2021
34763988
Corrigendum to 'SJS/TEN 2019: From science to translation' [J. Dermatol. Sci. 98/1 (2020) 2-12].
J Dermatol Sci
2021
32192826
SJS/TEN 2019: From science to translation.
J Dermatol Sci
2020
32192826
SJS/TEN 2019: From science to translation.
J Dermatol Sci
2020
29460415
Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.
Clin Pharmacol Ther
2018
29903854
Development of a consensus approach for return of pathology incidental findings in the Genotype-Tissue Expression (GTEx) project.
J Med Ethics
2018
29460415
Research Directions in the Clinical Implementation of Pharmacogenomics: An Overview of US Programs and Projects.
Clin Pharmacol Ther
2018
29903854
Development of a consensus approach for return of pathology incidental findings in the Genotype-Tissue Expression (GTEx) project.
J Med Ethics
2018
26857349
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
Clin Pharmacol Ther
2016
26857349
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.
Clin Pharmacol Ther
2016
25970446
Sharing and Specificity of Co-expression Networks across 35 Human Tissues.
PLoS Comput Biol
2015
25970446
Sharing and Specificity of Co-expression Networks across 35 Human Tissues.
PLoS Comput Biol
2015
24960519
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.
Clin Pharmacol Ther
2014
24960519
Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.
Clin Pharmacol Ther
2014
20045196
Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
Psychiatry Res
2010
20045196
Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
Psychiatry Res
2010
18521090
Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.
Mol Psychiatry
2009
19573479
Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
J Clin Psychiatry
2009
19150222
Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia.
Schizophr Res
2009
18521091
Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia.
Mol Psychiatry
2009
18521090
Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study.
Mol Psychiatry
2009
19573479
Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
J Clin Psychiatry
2009
19150222
Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia.
Schizophr Res
2009
18521091
Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia.
Mol Psychiatry
2009
18402937
Anti-apoptotic actions of vasopressin in H32 neurons involve MAP kinase transactivation and Bad phosphorylation.
Exp Neurol
2008
18303965
Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial.
Pharmacogenomics
2008
18402937
Anti-apoptotic actions of vasopressin in H32 neurons involve MAP kinase transactivation and Bad phosphorylation.
Exp Neurol
2008
18303965
Effect of a ciliary neurotrophic factor polymorphism on schizophrenia symptom improvement in an iloperidone clinical trial.
Pharmacogenomics
2008
17355321
Inhibition of vasopressin V1b receptor translation by upstream open reading frames in the 5'-untranslated region.
J Neuroendocrinol
2007
17355321
Inhibition of vasopressin V1b receptor translation by upstream open reading frames in the 5'-untranslated region.
J Neuroendocrinol
2007
17306778
Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress.
Brain Res
2007
17306778
Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress.
Brain Res
2007
16720725
Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway.
J Mol Endocrinol
2006
16720725
Vasopressin increases GAGA binding activity to the V1b receptor promoter through transactivation of the MAP kinase pathway.
J Mol Endocrinol
2006
15512850
Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation.
Stress
2004
15240381
Regulation of vasopressin V1b receptors and stress adaptation.
Ann N Y Acad Sci
2004
15512850
Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation.
Stress
2004
15240381
Regulation of vasopressin V1b receptors and stress adaptation.
Ann N Y Acad Sci
2004
12683934
Transcriptional and post-transcriptional mechanisms regulating the rat pituitary vasopressin V1b receptor gene.
J Mol Endocrinol
2003
12869588
Translational regulation of the vasopressin v1b receptor involves an internal ribosome entry site.
Mol Endocrinol
2003
12683934
Transcriptional and post-transcriptional mechanisms regulating the rat pituitary vasopressin V1b receptor gene.
J Mol Endocrinol
2003
12869588
Translational regulation of the vasopressin v1b receptor involves an internal ribosome entry site.
Mol Endocrinol
2003
12023277
Transcriptional regulation of the pituitary vasopressin V1b receptor involves a GAGA-binding protein.
J Biol Chem
2002
12444143
HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection.
J Immunol
2002
12023277
Transcriptional regulation of the pituitary vasopressin V1b receptor involves a GAGA-binding protein.
J Biol Chem
2002
12444143
HIV-1 protein Vpr suppresses IL-12 production from human monocytes by enhancing glucocorticoid action: potential implications of Vpr coactivator activity for the innate and cellular immunity deficits observed in HIV-1 infection.
J Immunol
2002
11264723
5Alpha-reductase type 2 and androgen receptor expression in gonadotropin releasing hormone GT1-1 cells.
J Neuroendocrinol
2001
11264723
5Alpha-reductase type 2 and androgen receptor expression in gonadotropin releasing hormone GT1-1 cells.
J Neuroendocrinol
2001
1 - 50 of 50
Column Actions
Search
Recommended Authors
Evaristus Nwulia
Howard University Hospital
Career Start Year
2006
Number of shared co-authors
3
Brinda K Rana
University of California
Career Start Year
1996
Number of shared co-authors
0
Catharina Lavebratt
Karolinska Institutet
Career Start Year
1994
Number of shared co-authors
0
Andrea Hofmann
Institute of Human Genetics, University of Bonn and Department of Genomics
Career Start Year
1991
Number of shared co-authors
0
Srdjan Djurovic
Oslo University Hospital
Career Start Year
1991
Number of shared co-authors
6
Marcella Rietschel
Central Institute of Mental Health, University of Mannheim
Career Start Year
1990
Number of shared co-authors
10
Albert H C Wong
Campbell Family Mental Health Research Institute
Career Start Year
1990
Number of shared co-authors
1
Andrew A Hicks
Institute for Biomedicine, Affiliated institute of the University of Lubeck
Career Start Year
1990
Number of shared co-authors
14
Russell A Wilke
University of South Dakota Sanford School of Medicine
Career Start Year
1989
Number of shared co-authors
43
Stuart C Sealfon
Icahn School of Medicine at Mount Sinai
Career Start Year
1988
Number of shared co-authors
0
G??rard Waeber
Centre hospitalier universitaire vaudois
Career Start Year
1986
Number of shared co-authors
13
Geraldina Dominguez
National Cancer Institute, National Institutes of Health
Career Start Year
1986
Number of shared co-authors
0
John L Black
Mayo Clinic
Career Start Year
1985
Number of shared co-authors
13
Peter R Schofield
University of New South Wales
Career Start Year
1984
Number of shared co-authors
4
David A Collier
Institute of Psychiatry, King's College London
Career Start Year
1984
Number of shared co-authors
6
Vidar M Steen
University of Oslo, Oslo University Hospital
Career Start Year
1984
Number of shared co-authors
5
James L Kennedy
Institute of Medical Sciences, University of Toronto
Career Start Year
1983
Number of shared co-authors
5
John R Kelsoe
University of California
Career Start Year
1982
Number of shared co-authors
7
Martin Schalling
Karolinska Institutet.
Career Start Year
1982
Number of shared co-authors
3
Stephen J Glatt
SUNY Upstate Medical University
Career Start Year
1981
Number of shared co-authors
3
Robert H Lipsky
George Mason University
Career Start Year
1980
Number of shared co-authors
0
Sevilla D Detera-Wadleigh
National Institute of Mental Health Intramural Research Program
Career Start Year
1979
Number of shared co-authors
0
Peter J Munson
and Blood Institute, National Institutes of Health
Career Start Year
1978
Number of shared co-authors
2
Wade H Berrettini
University of Pennsylvania
Career Start Year
1977
Number of shared co-authors
6
David Goldman
Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism.
Career Start Year
1976
Number of shared co-authors
2
Richard L Hauger
VA San Diego Healthcare System (VASDHS)
Career Start Year
1973
Number of shared co-authors
3
Richard H Goodman
Vollum Institute, Oregon Health & Science University
Career Start Year
1973
Number of shared co-authors
0
Stafford L Lightman
Bristol Medical School, University of Bristol
Career Start Year
1969
Number of shared co-authors
1
Wolfgang Sad??e
College of Medicine, The Ohio State University
Career Start Year
1967
Number of shared co-authors
18
John I Nurnberger
Stark Neurosciences Research Institute, Indiana University School of Medicine
Career Start Year
1952
Number of shared co-authors
6
row(s) 1 - 30 of 30
Collaborators
Greti Aguilera
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Co-authored papers
9
Dan M Roden
Vanderbilt University Medical Center
Co-authored papers
3
Marc S Williams
University of Washington Medical Center
Co-authored papers
3
Teri A Manolio
National Human Genome Research Institute
Co-authored papers
3
Laura J Rasmussen-Torvik
Northwestern University, Center for Genetic Medicine
Co-authored papers
3
Rex L Chisholm
Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University
Co-authored papers
3
Marylyn D Ritchie
Center for Systems Genomics, Pennsylvania State University, University Park
Co-authored papers
3
Joshua C Denny
Vanderbilt University
Co-authored papers
3
Brendan J Keating
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
2
Elizabeth J Phillips
Vanderbilt University Medical Center
Co-authored papers
2
Michael J Rieder
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers
2
Riichiro Abe
Co-authored papers
2
Maureen E Smith
Center for Genetic Medicine, Feinberg School of Medicine, Northwestern University
Co-authored papers
2
David S Carrell
Kaiser Permanente Washington Health Research Institute
Co-authored papers
2
Gail P Jarvik
University of Washington Medical Center
Co-authored papers
2
Vivian Pan
University of Illinois Cancer Center chicago
Co-authored papers
2
Melissa A Basford
Vanderbilt University
Co-authored papers
2
Kimberly F Doheny
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Co-authored papers
2
Sarah C Stallings
Vanderbilt University Medical Center
Co-authored papers
2
Cassandra L Perry
Boston Children's Hospital.
Co-authored papers
2
Murray H Brilliant
Marshfield Clinic Research Institute
Co-authored papers
2
Berta Almoguera
Center for Biomedical Research in Rare Diseases Network
Co-authored papers
2
Cynthia A Prows
Cincinnati Children's Hospital Medical Center
Co-authored papers
2
Bruce C Carleton
BC Children's Hospital Research Institute
Co-authored papers
2
James D Ralston
University of Washington.
Co-authored papers
2
Iftikhar J Kullo
Mayo Clinic
Co-authored papers
2
Eric B Larson
University of Washington
Co-authored papers
2
Cynthia Sung
Health Services and Systems Research, Duke-NUS Medical School
Co-authored papers
2
James Chodosh
Harvard Medical School
Co-authored papers
2
Josh F Peterson
Vanderbilt University Medical Center
Co-authored papers
2
1 - 30